Brown v. United States of America

District Court, D. South Carolina·Decided March 25, 2024·No. 2:21-cv-03801·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION

HARREY ANTHONY BROWN and ) KESHA LYNETTE BROWN, ) ) Plaintiffs, ) ) No. 2:21-cv-03801-DCN vs. ) ) ORDER UNITED STATES OF AMERICA, ) ) Defendant. ) ____________________________________)

This matter is before the court on plaintiffs Harrey Anthony Brown (“Mr. Brown”) and Kesha Lynette Brown’s (“Mrs. Brown”) (together, “plaintiffs”) motion for reconsideration of this court’s order, ECF No. 110, denying plaintiffs’ motion for summary judgment, ECF No. 61, and granting in part and denying in part defendants United States of America (the “United States” or the “government”), Dr. George J. Kallingal (“Dr. Kallingal”), and Grace E. Park’s (“Dr. Park”) (together, “defendants”) motion for summary judgment and motion for certification, ECF No. 75. ECF No. 136. For the reasons set forth below, the court grants the motion for reconsideration. I. BACKGROUND This case arises out of an allegedly failed medical procedure that Mr. Brown underwent in May 2019. Mr. Brown was diagnosed with prostate cancer in December 2018, and in March 2019, he and his wife attended a comprehensive prostate cancer clinic at the Brooke Army Medical Center (“BAMC”) Urology Clinic in Fort Sam Houston, Texas to discuss various treatment options. Plaintiffs allege that they met with Dr. Kallingal, a urology oncology surgeon at BAMC, who recommended that Mr. Brown undergo a robotic-assisted laparoscopic radical prostatectomy. Defendants dispute this account and claim that before meeting Dr. Kallingal, plaintiffs met with several other physicians. For example, defendants claim that on February 4, 2019, plaintiffs met with “Dr. Morales,” who purportedly wrote in his visit notes that he had recommended “active

surveillance” for Mr. Brown’s “very low risk prostate cancer.” ECF No. 75-5, Kallingal Decl. ¶ 11. Mr. Brown allegedly “still prefer[red] surgery,” so Dr. Kallingal met Mr. Brown for the first time on March 27, 2019. Id. ¶ 11, 13. At the visit, Mr. Brown elected to undergo the robotic-assisted laparoscopic prostatectomy. Plaintiffs allege that Dr. Kallingal claimed to possess “extensive experience and skill with performing the complex surgical procedure.” ECF No. 46, Amend. Compl. ¶ 13. Mr. Brown claims he consented to the surgery based on the understanding that Dr. Kallingal would serve as the primary surgeon “with no resident involvement.” Id. Dr. Kallingal disputes this, claiming that he did not represent that he would perform the surgery alone and that he would not have done so because “[a] robotic assisted

laparoscopic prostatectomy cannot be performed by one person.” Kallingal Decl. ¶ 19. According to plaintiffs, BAMC changed the “primary surgeon” from Dr. Kallingal to Dr. Park, a resident physician at BAMC. Amend. Compl. ¶ 13. Plaintiffs allege that Dr. Kallingal never obtained Mr. Brown’s authorization for Dr. Park to perform the procedure, and Dr. Kallingal instead falsified an informed consent form by forging Mr. Brown’s signature. Plaintiffs further allege that Dr. Park altered Mr. Brown’s surgical dictation notes and fabricated a surgical counseling session to show that she had visited with him prior to the surgery. Plaintiffs allege that due to Dr. Park’s lack of skill and experience, the procedure resulted in “severe post-operative complications,” including “a life-threatening illness and physical injuries to [Mr. Brown’s] body.” Amend. Compl. at 8 ¶ 14. Mr. Brown has been required to undergo additional medical procedures to treat the resulting injuries. Defendants dispute these claims. Instead, defendants assert that Dr. Park was the

Chief Resident and did not perform the surgery. As Chief Resident, Dr. Park conducted a preoperative clearance visit with Mr. Brown. ECF No. 75-6, Park Decl. ¶ 10. On the day of the surgery, Dr. Park provided bedside assistance by positioning, prepping, and draping the patient. Id. ¶ 13. Dr. Kallingal was the attending surgeon who controlled the robot and performed the operation on Mr. Brown on May 9, 2019. Kallingal Decl. ¶ 26. On November 19, 2021, plaintiffs, proceeding pro se, filed a complaint against the United States, Dr. Kallingal, and Dr. Park, as well as against BAMC and Dr. Alexander Ernest (“Dr. Ernest”). ECF No. 1. Plaintiffs filed an amended complaint on September 12, 2022, alleging three separate causes of action for negligence based on medical battery and medical malpractice. ECF No. 46, Amend. Compl. Pursuant to 28 U.S.C.

§ 636(b)(1)(A) and (B) and Local Civ. Rule 73.02(B)(2)(g) (D.S.C), all pretrial proceedings in this case were referred to Magistrate Judge Baker. On February 10, 2023, the court granted in part and denied in part defendants’ motion for substitution of parties and substituted the United States as a party for BAMC and Dr. Ernest. ECF No. 72. On November 15, 2022, plaintiffs filed a motion for summary judgment. ECF No. 61. Defendants responded in opposition on November 29, 2022, ECF No. 62, and plaintiffs replied on December 2, 2022, ECF No. 63. On April 3, 2023, defendants filed a motion for summary judgment and motion for certification. ECF No. 75. Plaintiffs responded to the motion on April 13, 2023. ECF No. 79. The magistrate judge issued a report and recommendation on June 14, 2023. ECF No. 101. On September 5, 2023, the court adopted the R&R and denied plaintiffs’ motion for summary judgment, ECF No. 61, and granted in part and denied in part defendants’ motion for summary judgment, ECF No. 75. ECF No. 110 (the “Summary Judgment Order”). In that order, the court

dismissed Drs. Kallingal and Park and substituted the United States in their place. Id. at 13. On February 21, 2024, plaintiffs, proceeding pro se, filed a motion for reconsideration of the Summary Judgment Order. ECF No. 136. On March 4, 2024, the government responded in opposition, ECF No. 140, and supplemented that response three days later on March 7, 2024, with additional documents that the government provided to the plaintiffs after the plaintiffs indicated that they had not seen those forms, ECF No. 143. Plaintiffs replied on March 11, 2024. ECF No. 144. The court held a status conference on March 18, 2024, in which plaintiffs further explained their position in response to the government’s supplement. ECF No. 147. As such, the motion is fully

briefed and now ripe for the court’s review. II. STANDARD A. Motion for Reconsideration A motion for reconsideration is generally raised via Rules 59 and 60 of the Federal Rules of Civil Procedure. Rule 59(e) allows a party to file a motion to alter or amend a judgment. Fed. R. Civ. P. 59(e). The rule provides an “extraordinary remedy which should be used sparingly.” Pac. Ins. Co. v. Am. Nat’l Fire Ins. Co., 148 F.3d 396, 403 (4th Cir. 1998) (internal quotation marks and citation omitted). When a motion to reconsider brought pursuant to Rule 59(e) is untimely, courts construe the motion as one filed under Rule 60(b). See Robinson v. Wix Filtration Corp. LLC, 599 F.3d 403, 412 (4th Cir. 2010); see also J.C. v. Fairfax Cnty. Pub. Schs., 2023 WL 5032784, at *1 n.1 (4th Cir. Aug. 8, 2023) (explaining that plaintiffs’ motion was filed more than 28 days after the district court entered its dismissal order, so the motion is properly construed

under Fed. R. Civ. P. 60(b)); Wriglesworth v. Esper, 765 F. App’x 6 (4th Cir. 2019) (per curiam) (same).

Free access — add to your briefcase to read the full text and ask questions with AI

Brown v. United States of America, (D.S.C. 2024).

Brown v. United States of America (Brown v. United States of America) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Robinson v. Wix Filtration Corp. LLC
599 F.3d 403 (Fourth Circuit, 2010)
Quijano v. United States
325 F.3d 564 (Fifth Circuit, 2003)
Pequeno v. Schmidt (In Re Pequeno)
126 F. App'x 158 (Fifth Circuit, 2005)
Hughes v. Rowe
449 U.S. 5 (Supreme Court, 1980)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Bonner
648 F.3d 209 (Fourth Circuit, 2011)
United States v. Jonathan Branch, A/K/A Jamal Jamal
970 F.2d 1368 (Fourth Circuit, 1992)
Miller Ex Rel. Miller v. HCA, INC.
118 S.W.3d 758 (Texas Supreme Court, 2003)
Murff v. Pass Ex Rel. Pass
249 S.W.3d 407 (Texas Supreme Court, 2008)
Henley v. FMC Corporation
20 F. App'x 108 (Fourth Circuit, 2001)
Haynes v. Beceiro
219 S.W.3d 24 (Court of Appeals of Texas, 2006)
Hood v. Phillips
554 S.W.2d 160 (Texas Supreme Court, 1977)
State v. Addington
588 S.W.2d 569 (Texas Supreme Court, 1979)